Abstract

Neonatal Abstinence Syndrome (NAS) is a withdrawal syndrome that occurs in newborns exposed to certain substances in utero, particularly opioids. As the opioid crisis continues to escalate, the prevalence of NAS has increased significantly, posing serious health challenges for affected infants and their families. This article examines the etiology, clinical manifestations, diagnosis, management strategies, and long-term outcomes associated with NAS. Understanding the complexities of this condition is essential for healthcare providers, caregivers, and policymakers to improve care for affected infants and address the broader societal issues linked to substance use during pregnancy.